 |
Discover ~ Translate ~ Cure |
|
Discover ~ Translate ~ Cure |
| Below is a list of representative publications by individual investigators at the UW Tumor Vaccine Group. To view the article, click on the article title.
You must have Adobe Reader to view these articles. If you do not have Adobe Reader, you can download it free from Adobe.com. |
Review Articles |
|
Use of tumour-responsive T cells as cancer treatment Disis ML, Bernhard H, Jaffee EM. Lancet. 373(9664): 673-83, 2009 | PubMed #19231634 |
|
A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers" Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, Coukos G, Dhodapkar M, Hakansson L, Janetzki S, Kleen TO, Kirkwood JM, Maccalli C, Maecker H, Maio M, Malyguine A, Masucci G, Palucka AK, Potter DM, Ribas A, Rivoltini L, Schendel D, Seliger B, Selvan S, Slingluff CL Jr, Stroncek DF, StreicherH, Wu X, Zeskind B, Zhao Y, Zocca MB, Zwierzina H, Marincola FM. J Translational Medicine. 6: 81, 2008 | PubMed #19105846 |
|
Translational Research Working Group developmental pathway for immune response modifiers. Cheever MA, Schlom J, Weiner LM, Lyerly HK, Disis ML, Greenwood A, Grad O, Nelson WG; Translational Research Working Group. Clinical Cancer Res. 14(18): 5692-9, 2008 | PubMed #18794077 |
|
Tumor stromal barriers to the success of adoptive T cell therapy Phan V and Disis ML Cancer Immunol Immunother 57(2): 281-3, 2008 | PubMed #17646987 |
|
Immune modulation as a therapeutic strategy for non-small-cell lung cancer Holt GE and Disis ML Clin Lung Cancer Suppl 1: S13-9, 2008 | PubMed #18540530 |
|
Cellular immune strategies for cancer therapy Disis ML, Jaffe EM and Bernhard H Lancet (in press), 2008 | Not Published Yet |
|
CD4 regulatory T cells in human cancer pathogenesis Knutson KL, Disis ML, Salazar LG. Cancer Immunol Immunother 56(3): 271-85, 2007 | PubMed #16819631 |
|
Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer Lu H, Goodell V, Disis ML. Expert Opin Ther Targets 11(2): 235-44, 2007 | PubMed #17227237 |
|
10th Biennial Helene Harris Memorial Trust Meeting Balkwill FR, Ashworth A, Bast RC, Berek J, Boyd J, Disis ML, Gabra H, Gore ME, Hamilton TC, Jacobs IJ, Kaye SB, Kohn EC, Mills GB, and Urban ND Cancer Research 66(6): 2904-6, 2006 | Not listed in PubMed |
|
Laboratory analysis of T cell immunity Knutson KL, dela Rosa C, and Disis ML Frontiers in Biosciences 11: 1932-44, 2006 | PubMed #16368569 |
|
Adoptive T cell therapy of solid cancers Knutson KL, Wagner W and Disis ML Immunol Immunother 55(1): 96-103, 2006 | PubMed #15891880 |
|
Progress in ovarian cancer research: Proceedings of the 5th Biennial Ovarian Cancer Research Symposium Disis ML, Rivkin SE, Baron A, Markman M, Connolly D, Ueland F, Kohne, Trimble E, Berek JS Int J of Gynecologic Cancer 16(2): 463-9, 2006 | Not listed in PubMed |
|
Tumor antigen specific CD4+ T cells in cancer immunity and immunotherapy Knutson KL and Disis ML Cancer Immunol Immunother 54(8): 721-8, 2005 | PubMed #16010587 |
|
Augmenting T helper cell immunity in cancer Knutson KL and Disis ML Curr Drug Targets Immune Endocr Metabol Disord 5(4): 365-71, 2005 | PubMed #16375690 |
|
Cancer Vaccines: The Role of Tumor Burden in Tipping the Scale Toward Vaccine Efficacy Salazar LG and Disis ML Journal of Clinical Oncology 23(30): 7397-8, 2005 | PubMed #16186591 |
|
Global Role of the Immune System in Identifying Cancer Initiation and Limiting Disease Progression Disis ML & Lyerly HK Journal of Clinical Oncology 23(35): 8923-5, 2005 | PubMed #16339754 |
|
Molecular Targeting With Cancer Vaccines Disis ML Journal of Clinical Oncology 23(22): 4840-1, 2005 | PubMed #15983394 |
|
Conflicts of interest in translational research Parks MR, Disis ML. J Translational Medicine. 2(1):28, 2004 | PubMed #15301694 |
|
Peptide-based vaccines in breast cancer Disis ML, Salazar LG, and Knutson KL Breast Dis 20: 3-11, 2004 | PubMed #15687702 |
|
Immune system versus tumor: shifting the balance in favor of DCs and effective immunity Kaufman HL and Disis ML J Clinical Investigation 113: 664-7, 2004 | PubMed #14991063 |
|
Clinical studies of vaccines targeting breast cancer Ko BK, Kawano K, Murray JL, Disis ML, Efferson CL, Kuerer HM, Peoples GE, Ioannides CG Clin Cancer Res 9: 3222-34, 2003 | PubMed #12960107 |
|
HER-2/neu Vaccines Disis ML, Schiffman K, Salazar LG, Almand B, and Knutson KL Cancer Chemother Biol Response Modif 21: 275-85, 2003 | PubMed #15338750 |
|
Immunotherapy of Glioblastoma Multiforme Knutson KL, Salazar L, Schiffman K, and Disis ML Expert Review of Neurotherapeutics 3(4): 511-23, 2003 | Not listed in PubMed |
|
Future directions in the management of ovarian cancer Disis ML and Rivkin S Hematol Oncol Clin North Am 17(4): 1075-85, 2003 | PubMed #12959192 |
|
Immunologic principles and immunotherapeutic approaches in ovarian cancer Knutson K, Curiel T, Salazar L, and Disis M Hematol Oncol Clin North Am 17(4): 1051-73, 2003 | PubMed #12959191 |
|
Monitoring immune responses in cancer patients receiving tumor vaccines Walker EW and Disis ML International Review of Immunology 22: 283-319, 2003 | PubMed #12745643 |
|
Toward a Breast Cancer Vaccine: Work in Progress-Review Knutson KL and Disis ML Oncology 17(9): 1217-8, 2003 | Not listed in PubMed |
|
Cancer vaccines targeting the HER-2/neu oncogenic protein Disis ML Biological Therapy of Breast Cancer 4(3): 11-4, 2002 | PubMed #11774201 |
|
Immunologic targets for breast cancer Disis ML Breast Disease 15: 83-90, 2002 | PubMed #15687648 |
|
Immunotherapy for breast cancer Knutson KL, Bishop MR, Schiffman K, and Disis ML Cancer Chemother Biol Response Modif 20: 351-69, 2002 | PubMed #12703214 |
|
Vaccination against the HER-2/neu oncogenic protein. Bernhard H, Salazar L, Schiffman K, Smorlesi A, Schmidt B, Knutson K, and Disis M Endocrine-related Cancer 9, 33-44, 2002 | PubMed #11914181 |
|
Adoptive T-cell therapy for the treatment of solid tumors Knutson KL, Almand B, Mankoff DA, Schiffman K, and Disis ML Expert Opinion on Biological Therapy 2(1): 55-66, 2002. | PubMed #11772340 |
|
Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society of Biologic Therapy Kielholz U, Weber J, Finke J, Gabrilovich D, Kast M, Disis ML, Kirkwood J, Scheibenbogen C, Scholm J, Maino V, Lyerly HK, See P, Storkus W, Marincola F, Worobec A, Atkins MB J of Immunotherapy, 25(2): 97-138, 2002 | PubMed #12074049 |
|
Clinical translation of peptide based vaccine trials: the HER-2/neu model Disis ML, Knutson KL, McNeel DG, Davis D, and Schiffman K Critical Reviews in Immunology 21(1-3): 263-73, 2001 | PubMed #11642608 |
|
Cancer vaccines targeting the HER-2/neu oncogenic protein Disis ML and Schiffman K Seminars in Oncology 6(Suppl 18): 12-20, 2001 | Not listed in PubMed |
|
Tumor vaccines for the management of prostate cancer McNeel DG and Disis ML Arch Immunol Ther Exp 48(2): 85-93, 2000 | PubMed #10807048 |
|
Vaccines for the treatment and prevention of non-small cell lung cancer Disis ML, West HL, and Schiffman K Clin Lung Cancer 1(4): 294-301, 2000 | PubMed #14733635 |
|
Peptide based tumor vaccines Disis ML, McNeel DG, Schiffman KA, Rinn K, and Knutson KL Current Opinion in Oncologic, Endocrine, and Metabolic Drugs 1(3): 253-9, 1999 | Not listed in PubMed |
|
Immunotherapeutic approaches to the treatment of breast cancer Knutson KL, Schiffman K, Rinn K, and Disis ML J Mammary Gland Biol and Neoplasia 4(4): 353-65, 1999 | PubMed #10705919 |
|
HER-2/neu orcogenic protein: issues in vaccine development Disis ML and Cheever MA Crit Rev Immunolo 18(1-2): 37-45, 1998 | PubMed #9419446 |
|
HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer Disis ML and Cheever MA Adv Cancer Res 71: 343-71, 1997 | PubMed #9111870 |
|
In vitro priming to tumor associated proteins Hand SL, Bernhard H, Huseby ES, Rubin WD, Disis ML, and Cheever MA Advances in Experimental Med Biol 417: 503-509, 1997 | PubMed #9286411 |
|
Oncogenic proteins as tumor antigens Disis ML and Cheever MA Curr Opin Immunol 8(5): 637-42, 1996 | PubMed #8902388 |
|
Immunity to oncogenic proteins Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, and Chen W Immunological Reviews 145: 33-59, 1995 | PubMed #7590829 |
|
Peptide vaccines for “self” tumor antigens Disis ML and Cheever MA Peptides: Chemistry, Structure and Biology, Kaumaya, PTP and Hodges, RS (Eds), Mayflower Scientific Ltd, Escom, Leiden, The Netherlands, 145: 752-4, 1995 | Not listed in PubMed |
|
Immunity to the HER-2/neu oncogenic protein Disis ML, Bernhard H, Gralow JR, Hand SL, Emery SR, Calenoff E, and Cheever MA Ciba Found Symp 187: 198-207, 1994 | PubMed #7540970 |